tert-butyl ((1S,3S)-3-formylcyclohexyl)carbamate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: tert-butyl ((1S,3S)-3-formylcyclohexyl)carbamate
• 英文别名: tert-butyl N-[(1S,3S)-3-formylcyclohexyl]carbamate
• 化学式: C₁₂H₂₁NO₃
• 分子量: 227.304
• InChiKey: HFZOJUONOHDPHP-UWVGGRQHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  tert-butyl ((1S,3S)-3-formylcyclohexyl)carbamate 、 4-(3-amino-1-(4-(4-hydroxypiperidin-1-yl)phenyl)-1H-pyrazol-5-yl)-2-fluorobenzonitrile 在 三乙酰氧基硼氢化钠 作用下， 以 二氯甲烷 为溶剂， 以60 %的产率得到tert-butyl ((1S,3S)-3-(((5-(4-cyano-3-fluorophenyl)-1-(4-(4-hydroxypiperidin-1-yl)phenyl)-1H-pyrazol-3-yl)amino)methyl)cyclohexyl)carbamate
  参考文献：
  名称：

  [EN] KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE
  [FR] INHIBITEURS DE KDM1A POUR LE TRAITEMENT D'UNE MALADIE

  摘要：

  Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDM1A, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.

  公开号：

  WO2023069884A1

文献信息

• [EN] KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS DE KDM1A POUR LE TRAITEMENT D'UNE MALADIE
  申请人：[en]IMAGO BIOSCIENCES, INC.

  公开号：WO2023069884A1

  公开（公告）日：2023-04-27

  Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDM1A, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.